J P Sevilla
Biographic Data
| ID | 6891870 |
|---|---|
| NAME | J P Sevilla |
| GIVEN NAMES | J P |
| FAMILY NAME | Sevilla |
| SIGNATURE | SEVILLA J P |
| AFFILIATIONS | Harvard Global Health Institute |
| ORCID | 0000-0001-9807-657X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Health and economic burdens of emerging infectious diseases in the USA, US territories and globally
INTRODUCTION: Emerging infectious diseases (EIDs) cause significant health and economic burdens in the USA and globally. Existing methods and analyses fall short of what is required to prioritise diseases for health technology research and development (R&D), including for medical countermeasure (MCM) development within rapid response frameworks by the Center for Biomedical Advanced Research and Development Authority, part of the Administration fo…
The global health and economic value of Covid-19 vaccination
INTRODUCTION: The COVID-19 pandemic triggered one of the largest global health and economic crises in recent history. COVID-19 vaccination (CV) has been the central tool for global health and macroeconomic recovery, yet estimates of CV's global health and macroeconomic value remain scarce. METHODS: We used regression analyses to measure the impact of CV on gross domestic product (GDP), infections and deaths. We combined regression estimates of va…
The Health-Augmented Lifecycle Model
There is a need to value health technologies in a way that accommodates their broader economic impacts and competing approaches for doing so have emerged. The Pareto principle (PP) requires policymakers to resolve intrapersonal trade-offs by deferring to the preferences of the individuals facing those trade-offs. Many broad value frameworks such as cost-utility analysis and its extensions, health-centric multicriteria decision analysis, and pover…
No prominent works on this page.
The global health and economic value of Covid-19 vaccination
INTRODUCTION: The COVID-19 pandemic triggered one of the largest global health and economic crises in recent history. COVID-19 vaccination (CV) has been the central tool for global health and macroeconomic recovery, yet estimates of CV's global health and macroeconomic value remain scarce. METHODS: We used regression analyses to measure the impact of CV on gross domestic product (GDP), infections and deaths. We combined regression estimates of va…
The Health-Augmented Lifecycle Model
There is a need to value health technologies in a way that accommodates their broader economic impacts and competing approaches for doing so have emerged. The Pareto principle (PP) requires policymakers to resolve intrapersonal trade-offs by deferring to the preferences of the individuals facing those trade-offs. Many broad value frameworks such as cost-utility analysis and its extensions, health-centric multicriteria decision analysis, and pover…
Health and economic burdens of emerging infectious diseases in the USA, US territories and globally
INTRODUCTION: Emerging infectious diseases (EIDs) cause significant health and economic burdens in the USA and globally. Existing methods and analyses fall short of what is required to prioritise diseases for health technology research and development (R&D), including for medical countermeasure (MCM) development within rapid response frameworks by the Center for Biomedical Advanced Research and Development Authority, part of the Administration fo…
Global health (2 works) · Pandemic (2 works) · Public health (2 works) · 2019-20 coronavirus outbreak (1 works) · Business (1 works) · Computer Science (1 works) · COVID-19 Pandemic Impacts (1 works) · Dengue fever (1 works) · Dengue vaccine (1 works) · Disease (1 works)